BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24704524)

  • 1. A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel disease.
    Vossenkämper A; Hundsrucker C; Page K; van Maurik A; Sanders TJ; Stagg AJ; Das L; MacDonald TT
    Gastroenterology; 2014 Jul; 147(1):172-83. PubMed ID: 24704524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.
    Philippe D; Chakass D; Thuru X; Zerbib P; Tsicopoulos A; Geboes K; Bulois P; Breisse M; Vorng H; Gay J; Colombel JF; Desreumaux P; Chamaillard M
    Gut; 2006 Jun; 55(6):815-23. PubMed ID: 16299031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory effects of the Chinese herbal formula FAHF-2 in experimental and human IBD.
    Song Y; Dunkin D; Dahan S; Iuga A; Ceballos C; Hoffstadter-Thal K; Yang N; Benkov K; Mayer L; Li XM
    Inflamm Bowel Dis; 2014 Jan; 20(1):144-53. PubMed ID: 24252977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression analysis of intestinal IL-8, IL-17 A and IL-10 in patients with celiac and inflammatory bowel diseases.
    Aghamohamadi E; Asri N; Odak A; Rostami-Nejad M; Chaleshi V; Hajinabi Y; Eslami M; Mohammadian Haftcheshmeh S; Gholam-Mostafaei FS; Asadzadeh-Aghdaei H; Masotti A; Zali MR
    Mol Biol Rep; 2022 Jul; 49(7):6085-6091. PubMed ID: 35526253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease.
    Autschbach F; Braunstein J; Helmke B; Zuna I; Schürmann G; Niemir ZI; Wallich R; Otto HF; Meuer SC
    Am J Pathol; 1998 Jul; 153(1):121-30. PubMed ID: 9665472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis and inflammation: role of adipokines in inflammatory bowel disease.
    Ponemone V; Keshavarzian A; Brand MI; Saclarides T; Abcarian H; Cabay RJ; Fletcher E; Larsen B; Durstine LJ; Fantuzzi G; Fayad R
    Clin Transl Gastroenterol; 2010 Oct; 1(10):e1. PubMed ID: 23238652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells.
    Ullrich KA; Derdau J; Baltes C; Battistella A; Rosso G; Uderhardt S; Schulze LL; Liu LJ; Dedden M; Spocinska M; Kainka L; Kubánková M; Müller TM; Schmidt NM; Becker E; Ben Brahim O; Atreya I; Finotto S; Prots I; Wirtz S; Weigmann B; López-Posadas R; Atreya R; Ekici AB; Lautenschläger F; Guck J; Neurath MF; Zundler S
    Gut; 2023 Nov; 72(11):2081-2094. PubMed ID: 37541770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine responsive networks in human colonic epithelial organoids unveil a molecular classification of inflammatory bowel disease.
    Pavlidis P; Tsakmaki A; Treveil A; Li K; Cozzetto D; Yang F; Niazi U; Hayee BH; Saqi M; Friedman J; Korcsmaros T; Bewick G; Powell N
    Cell Rep; 2022 Sep; 40(13):111439. PubMed ID: 36170836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-33 and inflammatory bowel diseases: lessons from human studies.
    Nunes T; Bernardazzi C; de Souza HS
    Mediators Inflamm; 2014; 2014():423957. PubMed ID: 24701033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal Inflammation and Regeneration-Interdigitating Processes Controlled by Dietary Lipids in Inflammatory Bowel Disease.
    Kwon SJ; Khan MS; Kim SG
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic manifestations of ocrelizumab-associated intestinal and hepatic injury in patients with multiple sclerosis.
    Challa B; Esnakula AK
    Histopathology; 2024 Apr; 84(5):765-775. PubMed ID: 38114289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell-mediated CD4 T-cell costimulation via CD86 exacerbates pro-inflammatory cytokine production during autoimmune intestinal inflammation.
    Gadjalova I; Heinze JM; Goess MC; Hofmann J; Buck A; Weber MC; Blissenbach B; Kampick M; Krut O; Steiger K; Janssen KP; Neumann PA; Ruland J; Keppler SJ
    Mucosal Immunol; 2024 Feb; 17(1):67-80. PubMed ID: 37918715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease.
    Stojancevic M; Stankov K; Mikov M
    Can J Gastroenterol; 2012 Sep; 26(9):631-7. PubMed ID: 22993736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass cytometry reveals systemic and local immune signatures that distinguish inflammatory bowel diseases.
    Rubin SJS; Bai L; Haileselassie Y; Garay G; Yun C; Becker L; Streett SE; Sinha SR; Habtezion A
    Nat Commun; 2019 Jun; 10(1):2686. PubMed ID: 31217423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Uptake Into Inflamed Human Intestinal Tissue and Immune Cell Targeting by Wormlike Polymer Micelles.
    Gardey E; Cseresnyes Z; Sobotta FH; Eberhardt J; Haziri D; Grunert PC; Kuchenbrod MT; Gruschwitz FV; Hoeppener S; Schumann M; Gaßler N; Figge MT; Stallmach A; Brendel JC
    Small; 2024 May; 20(21):e2306482. PubMed ID: 38109123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research Progress of Interleukin-27 in Inflammatory Bowel Disease.
    Wang Q; Chen F; Peng Y; Yi X; He Y; Shi Y
    Inflamm Bowel Dis; 2024 Feb; 30(2):303-310. PubMed ID: 37540894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine induced inflammatory bowel disease model using organ-on-a-chip technology.
    Tataru C; Livni M; Marean-Reardon C; Franco MC; David M
    PLoS One; 2023; 18(12):e0289314. PubMed ID: 38091316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency.
    Baldrich A; Althaus D; Menter T; Hirsiger JR; Köppen J; Hupfer R; Juskevicius D; Konantz M; Bosch A; Drexler B; Gerull S; Ghosh A; Meyer BJ; Jauch A; Pini K; Poletti F; Berkemeier CM; Heijnen I; Panne I; Cavelti-Weder C; Niess JH; Dixon K; Daikeler T; Hartmann K; Hess C; Halter J; Passweg J; Navarini AA; Yamamoto H; Berger CT; Recher M; Hruz P
    J Clin Immunol; 2024 Feb; 44(3):63. PubMed ID: 38363399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased inflammatory profile in oral leukoplakia tissue exposed to cold physical plasma ex vivo.
    Seebauer C; Freund E; Dieke T; Hasse S; Segebarth M; Rautenberg C; Metelmann HR; Bekeschus S
    J Oral Pathol Med; 2023 Nov; 52(10):1021-1028. PubMed ID: 37827138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation.
    Powell N; Lo JW; Biancheri P; Vossenkämper A; Pantazi E; Walker AW; Stolarczyk E; Ammoscato F; Goldberg R; Scott P; Canavan JB; Perucha E; Garrido-Mesa N; Irving PM; Sanderson JD; Hayee B; Howard JK; Parkhill J; MacDonald TT; Lord GM
    Gastroenterology; 2015 Aug; 149(2):456-67.e15. PubMed ID: 25917784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.